Table 1.
Comparison of patients’ demographic and clinical features before treatment
| Groups | N | Gender (M/F, n) | Age (years) | Marital status (M/U/D) | Duration of illness (months) | Baseline BPRS |
|---|---|---|---|---|---|---|
| Ari. | 39 | 21/18 | 26.31 ± 8.09 | 16/22/1 | 10.29 ± 13.29 | 54.49 ± 10.46 |
| Ris. | 43 | 22/21 | 32.37 ± 8.45 | 26/15/2 | 10.34 ± 15.67 | 54.12 ± 10.21 |
| Que. | 39 | 18/21 | 28.77 ± 8.31 | 19/17/3 | 4.41 ± 8.01 | 56.72 ± 11.46 |
| Ola. | 35 | 17/18 | 25.54 ± 6.93 | 15/19/1 | 9.29 ± 13.22 | 57.40 ± 14.90 |
| Zip. | 19 | 3/16 | 22.26 ± 5.41 | 7/12/0 | 7.31 ± 12.96 | 57.79 ± 15.34 |
| χ 2/F | 8.49 | 7.38 | 8.36 | 1.45 | 0.65 | |
| P value | > 0.05 | < 0.01 | > 0.05 | > 0.05 | > 0.05 |
Values are represented as mean ± SD; N: number of patients; M/F: male/female; Ari.: aripiprazole; Ris.: risperidone; Que.: quetiapine; Ola.: olanzapine; Zip.: ziprasidone. M: married; U: unmarried; D: divorced